What Is a 13-F Filing and Why Should You Care?
Every institutional investment manager with over $100 million in qualifying assets is required by the SEC to file a Form 13-F within 45 days of each calendar quarter's end. These filings disclose their complete long equity holdings — every stock, ETF, and convertible bond they own.
This means that four times a year, you get a window into the portfolios of the world's most sophisticated investors: Bridgewater, Renaissance Technologies, Berkshire Hathaway, Citadel, BlackRock, and thousands more.
The problem? There are over 5,300 institutional filers each quarter, collectively reporting positions in over 800,000 individual securities. No human can process all of it. That's where AI comes in.
*Note: The institutional data and analysis below is illustrative, designed to demonstrate how BioAlpha's AI processes 13-F filings. It does not constitute financial advice.*
Step 1: Understanding the 13-F Structure
A 13-F filing contains a few key pieces of information for each position:
| Field | What It Tells You | Example |
|---|---|---|
| Name of Issuer | The company | TESLA INC |
| CUSIP | Unique security ID | 88160R101 |
| Value (thousands) | Position size in $K | 4,521,000 |
| Shares/PRN Amount | Number of shares | 18,200,000 |
| Investment Discretion | Who decides | SOLE |
| Voting Authority | Who votes | SOLE |
What's NOT in a 13-F:
- Short positions (only longs are disclosed)
- Options strategies (only the underlying shares)
- The timing of purchases within the quarter
- The fund's reasoning for the position
Pro tip: The most valuable information in a 13-F isn't any single position — it's the *change* from the previous quarter's filing. New positions, increased stakes, and complete exits tell a story that the static snapshot doesn't.
Step 2: Calculating Quarter-Over-Quarter Changes
The real alpha in 13-F analysis comes from comparing consecutive filings. Here's what to calculate:
New Positions
Stocks that appear in the current filing but weren't in the previous one. These represent fresh conviction — the manager actively decided to initiate a position.
Increased Positions
Stocks where share count increased. Calculate the percentage increase to gauge how aggressively they're adding.
Decreased Positions
Stocks where share count dropped. Partial reductions may indicate profit-taking rather than loss of conviction.
Closed Positions
Stocks that were in the previous filing but disappeared entirely. These are the strongest negative signals — a full exit represents complete loss of thesis.
Position Change Classification
════════════════════════════════════════
NEW → First appearance in filing
INCREASED → Share count ↑ > 5%
MAINTAINED → Share count Δ < 5%
DECREASED → Share count ↓ > 5%
CLOSED → Removed from filing entirely
════════════════════════════════════════Step 3: Weighting by Manager Quality
Not all 13-F filers are created equal. A position change by Renaissance Technologies carries different implications than one from a small regional pension fund. BioAlpha's AI assigns a Manager Quality Score based on:
- 01Historical alpha generation — How much has this manager outperformed benchmarks over 1, 3, and 5 years?
- 02Position concentration — High-conviction portfolios (fewer positions) generate more meaningful signals than diversified index-huggers
- 03Turnover rate — Low-turnover managers make deliberate moves; high-turnover managers create noise
- 04AUM tier — Managers with $10B+ AUM face liquidity constraints that make their moves more calculated
Our system scores each of the 5,300+ filers and weights their position changes accordingly. The result: not all institutional moves are treated equally.
Case Study: What 13-F Filings Reveal About TSLA
To demonstrate this methodology, let's walk through how BioAlpha's AI analyzed the most recent round of 13-F filings for Tesla (TSLA). This is one of the most institutionally-debated stocks in the market, making it an ideal case study.
The Raw Numbers
After processing all Q4 2025 13-F filings (filed by mid-February 2026), our system aggregated the following TSLA positioning data:
┌────────────────────────────────────────────────────┐
│ TSLA — INSTITUTIONAL 13-F AGGREGATE — Q4 2025 │
├────────────────────────────┬───────────────────────┤
│ Total institutional filers│ 4,127 │
│ Filers holding TSLA │ 2,891 (70.1%) │
│ New positions initiated │ 187 │
│ Positions increased │ 943 │
│ Positions maintained │ 1,204 │
│ Positions decreased │ 412 │
│ Positions closed │ 145 │
├────────────────────────────┼───────────────────────┤
│ Net institutional bias │ ACCUMULATION │
│ Quality-weighted score │ +67.3 (scale: -100/+100)│
└────────────────────────────┴───────────────────────┘The Smart Money Signal
When we filter for only the top-quartile managers (by our Manager Quality Score), the picture sharpens considerably:
| Manager Tier | New/Increased | Decreased/Closed | Net Bias |
|---|---|---|---|
| Top 25% (by alpha) | 73% of positions | 27% of positions | Strong Buy |
| 25–50% | 61% of positions | 39% of positions | Moderate Buy |
| 50–75% | 48% of positions | 52% of positions | Neutral |
| Bottom 25% | 41% of positions | 59% of positions | Moderate Sell |
Interpretation: The highest-performing institutional managers are disproportionately accumulating TSLA, while lower-performing managers are reducing exposure. This "quality divergence" pattern is one of the most predictive signals in our 13-F analysis framework.
BioAlpha Insight: When top-quartile managers accumulate while bottom-quartile managers sell, the stock outperforms its sector by an average of +7.2% over the following quarter (backtested over 2,400 events since 2012).
Notable Individual Moves
Our AI also flags specific high-impact institutional moves:
- [Top Hedge Fund A] initiated a new $2.1B position — their largest new position of the quarter
- [Sovereign Wealth Fund B] increased their stake by 34%, adding 12.4M shares
- [Value-Oriented Fund C] — known for 3–5 year holding periods — initiated a position for the first time, signaling long-term thesis conviction
- [Activist Fund D] closed their entire $890M position — a negative signal worth monitoring
Step 4: Cross-Referencing with Other Signals
A 13-F signal alone doesn't make a trade. BioAlpha's platform cross-references institutional positioning with:
- Insider transactions — Are insiders buying alongside institutions, or selling into institutional demand?
- SEC filing language — Does the company's latest 10-K support the bullish thesis that institutions are positioning for?
- Options flow — Is the options market confirming or diverging from institutional equity positioning?
- Technical signals — Does the price action support accumulation patterns?
For TSLA, our cross-reference matrix currently shows:
TSLA SIGNAL CONVERGENCE MATRIX
═══════════════════════════════════════
13-F Institutional bias │ BULLISH ██████████░ 8.2/10
Insider transaction signal │ NEUTRAL █████░░░░░ 5.0/10
10-K filing sentiment │ BULLISH ███████░░░ 7.1/10
Options flow │ MIXED ██████░░░░ 6.3/10
Technical trend │ BULLISH ████████░░ 7.8/10
─────────────────────────────────────────
COMPOSITE │ LEAN BULLISH 6.9/10
═══════════════════════════════════════How to Do This Yourself (or Let AI Do It)
The Manual Approach
- 01Go to SEC EDGAR (sec.gov/cgi-bin/browse-edgar)
- 02Search for the institutional manager's name
- 03Filter for Form 13-F filings
- 04Download the XML or HTML version
- 05Compare against the previous quarter's filing
- 06Repeat for every manager you want to track
Time required: 15–30 minutes per manager. At 5,300+ filers, that's roughly 2,650 hours per quarter — the equivalent of 66 full-time analysts working an entire week.
The BioAlpha Approach
Our AI agents process all 5,300+ 13-F filings within 48 hours of the filing deadline. Every position change is aggregated, quality-weighted, cross-referenced with insider data, and scored automatically.
Subscribers receive:
- Real-time alerts when high-quality managers initiate or exit positions
- Quality-weighted institutional accumulation/distribution scores for every S&P 500 stock
- Cross-referenced signals combining 13-F data with insider transactions and filing analysis
Sign up for BioAlpha to get institutional-grade 13-F analysis without the 2,650-hour time commitment. Our AI does the heavy lifting — you make the decisions.
Key Takeaways
- 0113-F filings are a goldmine — but only if you can process all 5,300+ filers, not just the headline names
- 02Quarter-over-quarter changes matter more than static positions — look for new buys, aggressive increases, and complete exits
- 03Weight by manager quality — not all institutional moves carry equal predictive power
- 04Cross-reference everything — 13-F data is most powerful when combined with insider transactions, filing sentiment, and technical signals
- 05Speed matters — by the time 13-F analysis hits the financial press, most of the alpha has been priced in
*This analysis is illustrative and demonstrates BioAlpha's 13-F processing methodology. Institutional positioning data is for educational purposes. This content does not constitute financial advice. Always conduct your own due diligence before making investment decisions.*